ACE Technology Guidances

ACE Technology Guidances communicate recommendations from the MOH Drug Advisory Committee or the MOH Medical Technology Advisory Committee on the funding status and appropriate use of drugs, vaccines or medical technologies that have been evaluated by ACE. The guidances also include the Committee’s rationale for the funding recommendations, and key clinical and economic evidence which informed their deliberations. Plain English Summaries (PES) to explain ACE Technology Guidances are available for patients and the public.

Published on 30 Aug 2023
Last Updated on 30 Aug 2023
A- A+
Guidance Recommendations
The Ministry of Health’s Medical Technology Advisory Committee has recommended aortic hybrid stent graft for patients who:  
  • Require a two-stage repair for complex aortic disease extending into or beyond the distal aortic arch into the proximal descending aorta; AND
  • Do not need additional intervention (such as stent grafting) in the descending aorta.

Funding status

Aortic hybrid stent graft is recommended for inclusion on the MOH Medical Technology Subsidy List (MTSL). Listed models are recommended for subsidy when used in line with the abovementioned recommendations.

Aortic hybrid stent graft for treating complex aortic disease